Medication Station: Reducing Anticoagulation-Related Adverse Drug Events: Closely monitoring and managing risks for patients on warfarin

Source: Joint Commission Perspectives on Patient Safety, Volume 6, Number 7, July 2006 , pp. 3-4(2)

Publisher: Joint Commission Resources

Buy & download fulltext article:

Price: $10.00 plus tax (Refund Policy)

Abstract:

Approximately 2.5 million Americans require anticoagulant therapy, which means caregivers are often faced with the struggle of finding the perfect dose of warfarin that must avoid hemorrhagic complications while still sufficiently suppressing thrombosis. This article provides tips for prescribing the proper dosage of warfarin and also discusses the best way to involve patients in their warfarin management decisions.

Document Type: Research article

Publication date: 2006-07-01

More about this publication?

The Joint Commission Perspectives on Patient Safety gives readers how to information on analyzing and preventing errors in patient care. While this newsletter emphasizes prevention (a proactive approach), it also addresses the real-world issues of reacting to adverse events.
Editorial Board
Subscribe to this Title
ingentaconnect is not responsible for the content or availability of external websites